J.P. Morgan Private Wealth Advisors’s Pacira BioSciences PCRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | $343K | Buy |
11,185
+590
| +6% | +$18.1K | ﹤0.01% | 1406 |
|
2023
Q2 | $425K | Sell |
10,595
-11,323
| -52% | -$454K | ﹤0.01% | 1101 |
|
2023
Q1 | $894K | Buy |
21,918
+6,033
| +38% | +$246K | ﹤0.01% | 1209 |
|
2022
Q4 | $613K | Sell |
15,885
-7,554
| -32% | -$292K | ﹤0.01% | 1382 |
|
2022
Q3 | $1.25M | Buy |
23,439
+3,595
| +18% | +$191K | ﹤0.01% | 1038 |
|
2022
Q2 | $1.16M | Sell |
19,844
-4,703
| -19% | -$274K | ﹤0.01% | 1065 |
|
2022
Q1 | $1.87M | Sell |
24,547
-14,854
| -38% | -$1.13M | ﹤0.01% | 927 |
|
2021
Q4 | $2.37M | Buy |
39,401
+4,584
| +13% | +$276K | 0.01% | 839 |
|
2021
Q3 | $1.95M | Buy |
34,817
+149
| +0.4% | +$8.35K | ﹤0.01% | 914 |
|
2021
Q2 | $2.1M | Buy |
34,668
+16,097
| +87% | +$977K | 0.01% | 855 |
|
2021
Q1 | $1.3M | Sell |
18,571
-15,776
| -46% | -$1.11M | ﹤0.01% | 923 |
|
2020
Q4 | $2.06M | Buy |
34,347
+17,072
| +99% | +$1.02M | 0.01% | 719 |
|
2020
Q3 | $1.04M | Buy |
17,275
+2,443
| +16% | +$147K | ﹤0.01% | 875 |
|
2020
Q2 | $778K | Buy |
14,832
+5,801
| +64% | +$304K | ﹤0.01% | 898 |
|
2020
Q1 | $303K | Buy |
9,031
+1,289
| +17% | +$43.2K | ﹤0.01% | 1135 |
|
2019
Q4 | $351K | Sell |
7,742
-615
| -7% | -$27.9K | ﹤0.01% | 1172 |
|
2019
Q3 | $318K | Buy |
8,357
+2,438
| +41% | +$92.8K | ﹤0.01% | 1168 |
|
2019
Q2 | $257K | Sell |
5,919
-1,094
| -16% | -$47.5K | ﹤0.01% | 1208 |
|
2019
Q1 | $267K | Sell |
7,013
-467
| -6% | -$17.8K | ﹤0.01% | 1266 |
|
2018
Q4 | $322K | Buy |
7,480
+2,236
| +43% | +$96.3K | ﹤0.01% | 1137 |
|
2018
Q3 | $258K | Buy |
+5,244
| New | +$258K | ﹤0.01% | 1375 |
|
2018
Q1 | – | Sell |
-4,394
| Closed | -$201K | – | 1347 |
|
2017
Q4 | $201K | Buy |
+4,394
| New | +$201K | ﹤0.01% | 1189 |
|
2015
Q2 | – | Sell |
-2,560
| Closed | -$227K | – | 1118 |
|
2015
Q1 | $227K | Hold |
2,560
| – | – | ﹤0.01% | 992 |
|
2014
Q4 | $227K | Hold |
2,560
| – | – | ﹤0.01% | 956 |
|
2014
Q3 | $248K | Hold |
2,560
| – | – | ﹤0.01% | 904 |
|
2014
Q2 | $235K | Buy |
+2,560
| New | +$235K | ﹤0.01% | 769 |
|